Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma

BACKGROUND: Cell-free DNA (cfDNA) is being explored as biomarker for non-invasive diagnosis of cancer. We aimed to establish a cfDNA-based DNA methylation marker panel to differentially diagnose papillary thyroid carcinoma (PTC) from benign thyroid nodule (BTN). METHODS: 220 PTC- and 188 BTN patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Shubin, Lin, Bo, Xu, Minjie, Zhang, Quan, Huo, Zijun, Su, Mingyang, Ma, Chengcheng, Liang, Jinyu, Yu, Shuang, He, Qiye, Su, Zhixi, Li, Yanbing, Liu, Rui, Guo, Zhuming, Lv, Weiming, Xiao, Haipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996242/
https://www.ncbi.nlm.nih.gov/pubmed/36868052
http://dx.doi.org/10.1016/j.ebiom.2023.104497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996242/
https://www.ncbi.nlm.nih.gov/pubmed/36868052
http://dx.doi.org/10.1016/j.ebiom.2023.104497

Ejemplares similares